Lansoprazole Eg

Lansoprazole, the active ingredient in Lansoprazole Eg, is a proton pump inhibitor presented as an oral tablet for systemic use. It reduces gastric acid production and is used to manage conditions such as gastro‑esophageal reflux disease, peptic ulcer disease, erosive esophagitis and Helicobacter pylori eradication regimens.

GNH USA supplies Lansoprazole Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides sourcing for bulk and retail needs across regions.

Lansoprazole is a proton pump inhibitor used to treat acid‑related gastrointestinal disorders. - Gastro‑esophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of esophageal irritation. - Peptic ulcer disease: promotes ulcer healing by decreasing gastric acid secretion. - Erosive esophagitis: facilitates mucosal repair and symptom relief. - Helicobacter pylori eradication: used as part of combination therapy to improve eradication rates.

Lansoprazole may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools, often transient. - Nausea: feeling of stomach upset. - Abdominal pain: discomfort in the stomach area. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Acute interstitial nephritis: kidney inflammation. - Severe allergic reactions: rash, swelling, or anaphylaxis. - Low magnesium levels: may cause muscle cramps or cardiac arrhythmia.

Before prescribing Lansoprazole, clinicians should consider several safety considerations. - Assess renal function: dosage adjustment may be needed in severe impairment. - Review concomitant medications: potential for drug‑drug interactions. - Evaluate for osteoporosis risk: long‑term use may affect calcium absorption. - Monitor for infections: increased susceptibility to gastrointestinal infections. - Use with caution in pregnancy: limited data, weigh benefits versus risks. - Store at ambient temperature: keep in original container, protect from moisture and light.

Lansoprazole can affect the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid): - Antiretroviral protease inhibitors (e.g., atazanavir): reduced absorption, may lose efficacy. - Antifungal agents (e.g., ketoconazole, itraconazole): decreased bioavailability.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation. - Digoxin: reduced absorption, check serum levels. - Clopidogrel: diminished antiplatelet effect, consider alternative therapy. - Methotrexate: increased serum levels, monitor for toxicity.